Quotes 5-day view Delayed Nasdaq
01/21/2021
01/22/2021
01/25/2021
01/26/2021
01/27/2021
Date
118.11(c)
117.83(c)
117.95(c)
114.75(c)
111.13(c)
Last
139 961
107 939
74 084
67 859
345 272
Volume
-0.18% -0.24% +0.10% -2.71% -3.15% Change
Sales 2020
699 M - -
Net income 2020
88,1 M - -
Net Debt 2020
-
-
-
P/E ratio 2020
43,5x
Yield 2020
0,50%
Sales 2021
737 M - -
Net income 2021
99,0 M - -
Net Debt 2021
-
-
-
P/E ratio 2021
38,6x
Yield 2021
0,54%
Capitalization
3 595 M 3 595 M -
Capi. / Sales 2020
5,14x
Capi. / Sales 2021
4,88x
Nbr of Employees
1 341
Free-Float
98,9%
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products. The Human Nutrition & Health segment supplies ingredients in...
Notations Surperformance© of Balchem Corporation
Trading Rating : Investor Rating :
All news about BALCHEM CORPORATION
News in other languages on BALCHEM CORPORATION
Chart BALCHEM CORPORATION
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends BALCHEM CORPORATION
Short Term Mid-Term Long Term Trends Neutral Neutral Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
5
Average target price
112,80 $
Last Close Price
111,13 $
Spread / Highest target
15,2%
Spread / Average Target
1,50%
Spread / Lowest Target
-16,3%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
